Entourage Health to Hold First Quarter 2024 Financial Results Call on May 28
14 May 2024 - 9:30PM
Entourage Health
Corp. (
TSX-V:ENTG) (
OTCQX:
ETRGF) (
FSE:4WE)
(“
Entourage” or the “
Company”), a
Canadian producer and distributor of award-winning cannabis
products announced today it will file its first quarter 2024
financial statements and management’s discussion and analysis after
market close on Monday, May 27, 2024. Entourage will host a
conference call the following day on Tuesday, May 28, 2024, at
10:00 am Eastern Time to review the results and provide an
operational update.
Conference Call Details:
CEO and Executive Chair George Scorsis and CFO Vaani
Maharaj will host the conference call. Following the opening
remarks, management will be available for questions.
Date:Tuesday, May 28, 2024
Time:10:00 am Eastern Time
Dial-in Number:Canada/USA:
1-844-763-8274International Toll: 1-647-484-8814Participants,
please dial in and ask to join the Entourage call
Replay Dial-in:Canada/USA:
1-855-669-9658Replay Access Code: 0899Available after
12:00 p.m. Eastern Time until June 28, 2024
About Entourage Health
Corp.
Entourage Health Corp. is the publicly traded
parent Company of Entourage Brands Corp., a licence holder
producing and distributing cannabis products for the medical and
adult-use markets. The Company owns and operates a fully licensed
26,000 sq. ft. Aylmer, ON processing facility. With its Starseed
Medicinal medical-centric brand, Entourage has expanded its
multi-channelled distribution strategy. Starseed's industry-first,
exclusive partnership with LiUNA, the largest construction union in
Canada, along with employers and union groups, complements
Entourage's direct sales to medical patients. Entourage's elite
adult-use product portfolio includes Color Cannabis, Saturday
Cannabis – and now Dime Bag and Syndicate – sold across eight
provincial distribution agencies. Exclusive Canadian producer and
distributor of award-winning U.S.-based wellness brand Mary's
Medicinals, sold in both medical and adult-use channels in
addition, Entourage also entered into an exclusive agreement with
Irwin Naturals, nutraceutical and herbal supplement formulator of
popular branded wellness products sold across North
America.
Follow Entourage and its brands
on LinkedIn Instagram: Color
Cannabis, Saturday Cannabis, Starseed, Syndicate, Dime Bag
For Investor & Media
Enquiries:Catherine FlamanSenior Director, Communications
& Corporate
Affairs416-910-0279Catherine.flaman@entouragecorp.com
Forward Looking Information
This press release contains "forward-looking information" within
the meaning of applicable Canadian securities legislation which are
based upon Entourage's current internal expectations, estimates,
projections, assumptions and beliefs and views of future events.
Forward looking information can be identified using forward-looking
terminology such as "expect," "likely," "may," "will," "should,"
"intend," "anticipate," "potential," "proposed," "estimate" and
other similar words, including negative and grammatical variations
thereof, or statements that certain events or conditions "may,"
"would" or "will" happen, or by discussions of strategy.
The forward-looking information in this news
release is based upon the expectations, estimates, projections,
assumptions, and views of future events which management believes
to be reasonable in the circumstances. Forward looking information
includes estimates, plans, expectations, opinions, forecasts,
projections, targets, guidance, or other statements that are not
statements of fact. Forward looking information necessarily involve
known and unknown risks, including, without limitation, risks
associated with general economic conditions; adverse industry
events; loss of markets; future legislative and regulatory
developments; inability to access sufficient capital from internal
and external sources, and/or inability to access sufficient capital
on favourable terms; the cannabis industry in Canada generally; the
ability of Entourage to implement its business strategies;
competition; crop failure; and other risks.
Any forward-looking information speaks only as
of the date on which it is made, and, except as required by law,
Entourage does not undertake any obligation to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise. New factors emerge from
time to time, and it is not possible for Entourage to predict all
such factors. When considering this forward-looking information,
readers should keep in mind the risk factors and other cautionary
statements in Entourage's disclosure documents filed with the
applicable Canadian securities regulatory authorities and available
on SEDAR+ at www.sedarplus.ca. The risk factors and other factors
noted in the disclosure documents could cause actual events or
results to differ materially from those described in any
forward-looking information.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS
REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE
POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Entourage Health (TSXV:ENTG)
Historical Stock Chart
From Nov 2024 to Dec 2024
Entourage Health (TSXV:ENTG)
Historical Stock Chart
From Dec 2023 to Dec 2024